Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EMN 2018 | Novel avenues for MM treatment: CAR T-cells, venetoclax, induction & MRD

Nikhil Munshi, MD, of the Dana-Farber Cancer Institute, Boston, MA, discusses exciting novel avenues for multiple myeloma (MM) therapy from the 1st European Myeloma Network (EMN) Meeting, in Turin, Italy. Dr Munshi covers BCMA-targeting CAR T-cells, venetoclax, induction regimens and measurable residual disease monitoring.